Veraxa Biotech Holding AG
VRXA----
Veraxa Biotech Holding AG (VRXA)
Veraxa Biotech AG develops antibody-based therapeutics and antibody-drug conjugates for cancer treatment. The company develops antibody-based therapeutics, incl...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
News
- PUBT · 1 day ago, 06:02 AM
Veraxa Biotech names Christoph Erkel chief scientific officer, succeeding Rick Austin
- PUBT · Jul 20 at 06:01 AM
Veraxa Biotech receives PEI scientific advice on BiTAC-TCE development plan
- businessinsider · Jul 13 at 12:15 PM
VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Development
- Simplywall · Jul 13 at 08:16 AM
AI Chips Today - AI Advancements Revolutionize Drug Discovery and Cancer Treatment
- PUBT · Jul 13 at 06:00 AM
Veraxa Biotech partners with Ardigen on AI-enabled drug discovery for BiTAC pipeline
- benzinga_article · Jul 13 at 01:35 AM
FB Financial, Smith Micro Software And 3 Stocks To Watch Heading Into Monday
